GC CELL CORPORATION

107 Ihyeon-ro 30beon-gil, Giheung-gu, Yongin, Gyeonggi, South Korea

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

40.0%

Phase 2

26.7%

Phase 3

20.0%

Trial Status Distribution

Completed

60.0%

Recruiting

13.3%

Unknown

13.3%

Withdrawn

13.3%

Clinical Trials

Trials sponsored by this organization (15)

Phase 1 to Investigate the Safety, Tolerability, and Efficacy of GCC2005 in Patients With R/R NK and T-cell Malignancies

Phase 1

Recruiting

interventional

Mar 202553 participants

Phase 1 Clinical Trial to Evaluate the Safety and Anti-Tumor Activity of AB-201

Phase 1

Withdrawn

interventional

Oct 202448 participants

Retrospective Study of Long-Term Survival of "Immuncell-LC" in Patients Undergoing Curative Resection for HCC in Korea

Completed

observational

Sep 2024230 participants

Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With ARDS

Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of CT303 in Patients With Psoriasis

Phase 1

Unknown

interventional

Oct 202124 participants

Safety and Efficacy of Immuncell-LC With Gemcitabine in Resectable Pancreatic Cancer

Phase 3

Recruiting

interventional

Sep 2021408 participants

Evaluate the Efficacy and Safety of 'Immuncell-LC' in Patients Undergoing Liver Transplantation

Phase 1

Completed

interventional

Jan 201919 participants

MG4101 Plus Rituximab Including Lymphodepletion in Patient With r/r NHL B-cell Origin

Phase 1

Unknown

interventional

Nov 20189 participants

Page 1 of 2

Approvals

No approval data available

News

No news articles found

Back to Organizations